Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Structure (London, England : 1993)|August 22, 2024
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spikeHelen M E Duyvesteyn, Aiste Dijokaite-Guraliuc, Chang Liu, et al.Nature Communications|March 29, 2024
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86Daming Zhou, Piyada Supasa, Chang Liu, et al.Nature Communications|April 16, 2024
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infectionChang Liu, Raksha Das, Aiste Dijokaite-Guraliuc, et al.Nature Communications|June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapyManon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.Science Translational Medicine|June 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adultsYingyun Cai, Seme Diallo, Kim Rosenthal, et al.Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.Pageof 2